Powered by Bioz
Starting at: $859.00
| SKU | Package Size | Price | Quantity | Add to Cart |
|---|---|---|---|---|
| 10HU-051 | Cryopreserved, 0.5 million cells/vial | Starting at: $859.00 |
Product Description
The human brain microvascular endothelial cells (HBMVEC) are the major element of the blood-brain barrier that shields the brain against toxins and immune cells via paracellular, transcellular, transporter, and extracellular matrix proteins [1]. HBMVEC are morphologically different from the peripheral endothelium. Brain endothelial cells lack fenestrations, have minimal pinocytic activity, are connected by tight junctions and have a large number of mitochondria associated with high metabolic activity [2]. Like peripheral endothelial cells, however, HBMVEC express, or can be induced to express, cell adhesion molecules on their surface that regulate the extravasation of leukocytes into the brain. HBMVEC have been widely used for studying the molecular and cellular function of blood-brain barrier [3].
iXCells Biotechnologies provides high quality HBMVEC, which are isolated from human brain and cryopreserved at P1, with ≥ 0.5 million cells in each vial. These HBMVEC express von Willebrand Factor (vWF), CD31 (PECAM), and Dil-Ac-LDL by uptake. They are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast, and fungi and can be further expanded for no more than 3 passages in Endothelial Cell Growth Medium (Cat# MD-0010) under the conditions suggested by iXCells Biotechnologies. Further expansion may decrease the purity.
Figure 1. Phase contrast image of HBMVEC on day 1 and day 3 post recovery. Immunofluorescence staining of HBMVEC with antibodies against CD31 (Red) and vWF (Green).
Product Details
| Tissue | Human brain |
| Package Size | 0.5 millioncells/vial |
| Passage Number | P1 |
| Shipped | Cryopreserved |
| Storage | Liquid nitrogen |
| Growth Properties | Adherent |
| Media | Endothelial Cell Growth Medium (Cat# MD-0010) |
References
[1] Abbott, N. J., Patabendige, A. A., Dolman, D. E., Yusof, S. R., & Begley, D. J. (2010). Structure and function of the blood-brain barrier. Neurobiology of disease, 37(1), 13–25.
[2] Yang, C., Hawkins, K. E., Doré, S., & Candelario-Jalil, E. (2019). Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. American journal of physiology. Cell physiology, 316(2), C135–C153.
[3] Godinho-Pereira, J., Garcia, A. R., Figueira, I., Malhó, R., & Brito, M. A. (2021). Behind Brain Metastases Formation: Cellular and Molecular Alterations and Blood-Brain Barrier Disruption. International journal of molecular sciences, 22(13), 7057.
Alghamri, M. S., Banerjee, K., Mujeeb, A. A., Mauser, A., Taher, A., Thalla, R., McClellan, B. L., Varela, M. L., Stamatovic, S. M., Martinez-Revollar, G., Andjelkovic, A. V., Gregory, J. V., Kadiyala, P., Calinescu, A., Jiménez, J. A., Apfelbaum, A. A., Lawlor, E. R., Carney, S., Comba, A., … Castro, M. G. (2022). Systemic delivery of an adjuvant CXCR4–CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy. ACS Nano, 16(6), 8729–8750. https://doi.org/10.1021/acsnano.1c07492 -- Learn More
Ranjan, N., Pandey, V., Panigrahi, M. K., Klumpp, L., Naumann, U., & Babu, P. P. (2021). The Tumor Suppressor MTUS1/ATIP1 Modulates Tumor Promotion in Glioma: Association with Epigenetics and DNA Repair. Cancers, 13(6), 1245. -- Learn More
Ozek, C., Krolewski, R. C., Buchanan, S. M., & Rubin, L. L. (2018). Growth differentiation FACTOR 11 treatment leads to neuronal and Vascular improvements in the hippocampus of aged mice. Scientific Reports, 8(1). doi:10.1038/s41598-018-35716-6 -- Learn More
FREQUENTLY BOUGHT TOGETHER - RECOMMENDED FOR YOU!